We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Urine Biomarker Test to Enable Accurate Diagnosis of Diabetic Kidney Disease

By LabMedica International staff writers
Posted on 20 Jul 2023
Print article
Image: In-depth urinary and exosome proteome profiling analysis has identified novel biomarkers for diabetic kidney disease (Photo courtesy of Freepik)
Image: In-depth urinary and exosome proteome profiling analysis has identified novel biomarkers for diabetic kidney disease (Photo courtesy of Freepik)

Diabetic kidney disease (DKD), a major microvascular complication of type 2 diabetes mellitus (T2DM), results in permanent kidney damage and poor prognosis for the affected patients. For individuals with T2DM, particularly those with a prolonged disease history, early detection and monitoring of kidney damage are critical. Now, a team of researchers who conducted a comprehensive analysis of urinary and exosome proteome profiling has uncovered novel biomarkers for DKD.

In a collaborative study involving researchers from the Chinese Academy of Sciences (Shanghai, China), the team carried out extensive urinary proteomics and urinary exosome proteomics studies on T2DM patients exhibiting varying levels of albuminuria. The study involved 144 clinical patients, from whom 144 urine samples were collected. This included 19 healthy controls and 125 T2DM patients at various stages (74 at DM1 stage with ACR value < 30 mg/g, 36 at DM2 stage with 30 mg/g ≤ ACR value ≤ 300 mg/g, and 15 at DM3 stage with ACR value > 300 mg/g). This helped the team uncover the dynamic attributes of urinary and exosome proteomes in T2DM patients with varying albuminuria levels. All proteins were grouped into six clusters based on their expression patterns throughout DKD's progression.

The research revealed that proteins involved in glycolysis and ubiquitination processes experienced a dramatic drop from healthy control to DM1 stage, followed by a slow decline from DM1 to DM3 stage. Proteins associated with lipid transport and cholesterol esterification progressively increased as DKD advanced, peaking at the DM3 stage. Proteins mainly engaged in carbohydrate metabolic processes exhibited high expression in T2DM patients and then decreased as DKD progressed. Moreover, the team identified and validated a series of proteins like SERPINA1 and TF in another cohort of diabetic urine samples at different DKD stages. These proteins hold potential as future biomarkers for DKD diagnosis or disease monitoring, thereby offering a valuable resource for identifying potential urinary biomarkers in DKD patients.

Related Links:
Chinese Academy of Sciences 

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more